Abstract: Systems, methods, and apparatuses are provided for supporting barcoded service requests and responses. The systems, methods, and apparatuses can support receiving, from a pharmacy computer, a claim request that identifies at least a patient and a prescribed product; determining, based upon the claim request, that a service request is available, the service request indicating an opportunity for one or more services to be provided by the pharmacy to the patient; storing claim information in association with a bar code, the claim information including information from the claim request, the bar code associated with the service request; automatically directing a delivery of the service request to the pharmacy, the service request including the bar code; and receiving a response to the service request, wherein the response includes the bar code, where the bar code is utilized, at least in part, to obtain at least a portion of the claim information for documentation of the one or more provided services.

Abstract: Technologies are described herein for suggesting long-tail tags. A first group of tags and a second group of tags are identified from a plurality of tags. The first group of tags includes frequently-assigned tags having a higher frequency of being assigned to an asset. The second group of tags includes long-tail tags having a lower frequency of being assigned to the asset than the frequently-assigned tags. The frequently-assigned tags and a sample of the long-tail tags are suggested to a user upon receiving a request from the user to tag the asset.

Abstract: Methods, systems, and computer-readable media for finding similarities between visual objects using keywords and computerized visual image analysis are provided. A visual object may be provided as an input. A group of visual objects sharing keywords with the visual object may be generated for further analysis. The visual similarity of this group of visual objects may then be determined using computerized visual analysis. A group of visual objects that have the highest similarity rank, as determined by the computerized visual analysis, may then be displayed.

Abstract: Technologies are described herein for suggesting long-tail tags. A first group of tags and a second group of tags are identified from a plurality of tags. The first group of tags includes frequently-assigned tags having a higher frequency of being assigned to an asset. The second group of tags includes long-tail tags having a lower frequency of being assigned to the asset than the frequently-assigned tags. The frequently-assigned tags and a sample of the long-tail tags are suggested to a user upon receiving a request from the user to tag the asset.

Abstract: A user interface for a general purpose laser treatment system is provided. Generally, the user interface may be associated with a carbon dioxide (CO2) laser for use in various surgical procedures, for example, veterinary or medical surgical procedures. A treatment atlas including a collection of treatment procedures is stored within a database structure. The treatment procedures includes laser settings associated with each of the treatment procedures. The interface can provide a recommended treatment procedures to a user based on required application. The treatment atlas can be accessed through the internet and requested treatment procedures (and the corresponding laser settings) can be downloaded to a laser treatment system. The treatment atlas can also be a component of a Web 2.0 social networking system to enable users and system administrators to update and modify the collection of treatment procedures.

Abstract: The present invention relates to new class of non-steroidal compounds which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory- and immune-associated diseases, and have the structure including all stereoisomers thereof, tautomers thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, wherein X is selected from N, O, and S; Y is N or CR6; Z is a ring; and where R, Ra, Rb, Rc, Rd, R1, R2, R3, R4, and R5 are as defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising such compounds.

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein B, J, K, Z, R, Ra, Rb, Rc, Rd, Rq, Rw, m and n are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract: An interface for accessing data from one or more information systems using a wireless telephone or other user device. The interface is presented to a user as an abstraction of a unified mailbox and permits access by the user to messaging and other services from the wireless device. The interface is coupled to one or more converting modules to convert user inputs from the format in which they are received into a format that may be input to the desired information system.

Abstract: Certain embodiments include a method for a first covering group member belonging to a covering group of using a request list containing a request list component for each of the covering group members. The covering group containing at least two covering group members. Each of the request list components further contains a request summary collection containing at least a past-due request summary and a immediately-due request summary. The method includes the user performing the following. Selecting a second of the covering group members belonging to the covering group. Selecting a first of the summaries of the request summary collection contained in the request list component for the second covering group member.

Abstract: Non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or an enantiomer, a diastereomer, a pharmaceutically acceptable salt, or hydrate thereof, where J is selected from NR1 or C(R4)(R4a); K is selected from NR2 or C(R5)(R5a); L is selected from NR3 or C(R6)(R6a); and A, X, Y, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R8, R10, R11, and n are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract: The present application provides benzoxazole inhibitors of 15-LO, pharmaceutical compositions containing such inhibitors and methods for treating diseases related to the 15-LO cascade using such compounds and compositions.

Abstract: The present invention is directed to uses of GM-284 for enhancing epithelial cell proliferation. The present invention is also provides methods for treating a keratinocyte-associated disorder in a subject in need of treatment.

Abstract: The present invention is directed to methods for modulating gene expression in an epithelial cell.

Abstract: The present invention provides an automatic control system, method and paper manufacturing machine using such control system for automatically controlling the amount of press section dewatering via the metered application of chemical dewatering agents applied to a paper web in a paper manufacturing process. The control system includes a feedback controller for controlling the amount of chemical dewatering agent applied to a paper web, and a monitoring device for obtaining a measurement of the moisture of the paper web exiting the press section.

Abstract: The present invention relates to new class of non-steroidal compounds which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory- and immune-associated diseases, and have the structure including all stereoisomers thereof, tautomers thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, wherein X is selected from N, O, and S; Y is N or CR6; Z is a ring; and where R, Ra, Rb, Rc, Rd, R1, R2, R3, R4, and R5 are as defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract: The present invention provides indole inhibitors of 15-LO, pharmaceutical compositions containing such inhibitors and methods for treating diseases related to the 15-LO cascade using such compounds and compositions.

Abstract: A belt conditioning method, apparatus and paper machine employing the method and apparatus are provided. The belt method and apparatus include multiple conditioning devices using chemicals to condition water impermeable surfaces of paper machine belts, such as transfer belts and prevent deposits from accumulating on the belts. In one embodiment, the belt supports a web at a first portion of the belt's loop and is separated from the web at a second portion. The conditioning apparatuses are placed in the second portion.

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein B, J, K, Z, R, Ra, Rb, Rc, Rd, Rq, Rw, m and n are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or stereoisomers or prodrugs or solvates or pharmaceutically acceptable salts thereof, wherein A, B, J, K, Z, R, Ra, Rb, Rc, and Rd, are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract: Heterocyclic are provided which are sodium/proton exchange (NHE) inhibitors which have the structure wherein n is 1 to 5; X is N or C—R5 wherein R5 is H, halo, alkenyl, alkynyl, alkoxy, alkyl, aryl or heteroaryl; Z is a heteroaryl gorup, R1, R2, R3 and R4 are as defined herein, and where X is N, R1 is preferably aryl or heteroaryl, and are useful as antianginal and cardioprotective agents. In addition, a method is provided for preventing or treating angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia employing the above heterocyclic derivatives.